How is Sirolimus Protein-Bound Intravenous Route dosed?
The recommended dose of sirolimus protein-bound injection for the treatment of perivascular epithelioid cell tumor (PEComa) is 3 mg/m^2 as an intravenous infusion over 60 minutes every 3 weeks. The dosage and frequency of administration are determined by the patient's medical condition, response to treatment, and other factors. It is crucial to follow the dosage instructions provided by your doctor, as they may vary depending on individual factors. Sirolimus protein-bound injection is typically given by a healthcare professional in a hospital or clinical setting. The drug is available in powder form for suspension, which is reconstituted before use.
What is the dosage form of Sirolimus Protein-Bound Intravenous Route?
The dosage forms of sirolimus protein-bound injection for intravenous route are Powder for Suspension.
How is Sirolimus Protein-Bound Intravenous Route administered?
Sirolimus protein-bound injection is administered through the intravenous (IV) route, which means it is injected directly into a vein. This medicine is given only by or under the direct supervision of a healthcare professional. It is available in the form of a powder for suspension, which is reconstituted before use.
What are common precautions when taking Sirolimus Protein-Bound Intravenous Route?
When taking sirolimus protein-bound injection, common precautions to consider include:
- Inform your doctor about any allergies or unusual reactions to medications, foods, dyes, preservatives, or animals.
- Discuss any other types of allergies, including those related to foods or other products, with your healthcare professional.
- Do not take any immunizations (live vaccines) without your doctor's approval while being treated with sirolimus protein-bound injection.
- Consult your doctor if you have concerns about the risk of transmitted viruses through the use of human blood products.
- Avoid taking other medications, including prescription, nonprescription (over-the-counter), herbal, or vitamin supplements, without your doctor's permission.
- Be cautious about potential side effects and seek medical attention if you experience any of the following: bleeding gums, rash, itching, large hive-like swelling, swelling of face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs, red and swollen skin, difficulty breathing, trouble swallowing, or chest tightness.
- Talk to your doctor about the possibility of infertility associated with this medication before using it if you plan to have children. Please note that the information provided does not include the brand name Fyarro.